Methylprednisolone Completed Phase 2 Trials for Graft Versus Host Disease (GVHD) / Myelodysplastic Syndromes (MDS) / Leukemias Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00458848Chemotherapy With or Without Imatinib and/or Peripheral Stem Cell Transplant in Acute Lymphoblastic Leukemia
NCT00002833Peripheral Stem Cell Transplantation Plus Filgrastim in Treating Patients With Acute or Chronic Myelogenous Leukemia
NCT00002785Combination Chemotherapy, Bone Marrow Transplantation, and Radiation Therapy in Treating Infants With Acute Lymphoblastic Leukemia
NCT00022126Combination Chemotherapy With or Without Donor Bone Marrow Transplantation in Treating Infants With Previously Untreated Acute Lymphoblastic Leukemia
NCT02176031Phase II Trial of Natalizumab + Prednisone for Initial Therapy of Acute GI GVHD
NCT00609609Photopheresis for the Treatment of Acute Graft Versus Host Disease